These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 8769682)

  • 1. Characteristics of low density lipoprotein isolated from circulating immune complexes.
    Tertov VV; Sobenin IA; Orekhov AN; Jaakkola O; Solakivi T; Nikkari T
    Atherosclerosis; 1996 May; 122(2):191-9. PubMed ID: 8769682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple-modified desialylated low density lipoproteins that cause intracellular lipid accumulation. Isolation, fractionation and characterization.
    Tertov VV; Sobenin IA; Gabbasov ZA; Popov EG; Jaakkola O; Solakivi T; Nikkari T; Smirnov VN; Orekhov AN
    Lab Invest; 1992 Nov; 67(5):665-75. PubMed ID: 1434544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of desialylated low-density lipoproteins which cause intracellular lipid accumulation.
    Tertov VV; Sobenin IA; Orekhov AN
    Int J Tissue React; 1992; 14(4):155-62. PubMed ID: 1478792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies against low-density lipoprotein and atherogenic potential of blood.
    Kacharava AG; Tertov VV; Orekhov AN
    Ann Med; 1993 Dec; 25(6):551-5. PubMed ID: 8292305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid composition of circulating multiple-modified low density lipoprotein.
    Zakiev ER; Sukhorukov VN; Melnichenko AA; Sobenin IA; Ivanova EA; Orekhov AN
    Lipids Health Dis; 2016 Aug; 15(1):134. PubMed ID: 27558696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naturally occurring modified low density lipoproteins are similar if not identical: more electronegative and desialylated lipoprotein subfractions.
    Tertov VV; Bittolo-Bon G; Sobenin IA; Cazzolato G; Orekhov AN; Avogaro P
    Exp Mol Pathol; 1995 Jun; 62(3):166-72. PubMed ID: 8612720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Carbohydrate composition of native and desialylated low density lipoproteins in the plasma of patients with coronary atherosclerosis].
    Tertov VV; Sobenin IA; Gevara Kh; Morrisett DD; Orekhov AN
    Kardiologiia; 1992 Sep; 32(9-10):57-61. PubMed ID: 1287315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbohydrate composition of circulating multiple-modified low-density lipoprotein.
    Zakiev ER; Sobenin IA; Sukhorukov VN; Myasoedova VA; Ivanova EA; Orekhov AN
    Vasc Health Risk Manag; 2016; 12():379-385. PubMed ID: 27789955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Atherogenesis in human - clinical aspects of circulating immune complexes].
    Babintseva YD; Sergeeva AM; Karagodin VP; Orekhov AN
    Klin Med (Mosk); 2016; 94(5):325-32. PubMed ID: 30289642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low density lipoprotein-containing circulating immune complexes: role in atherosclerosis and diagnostic value.
    Sobenin IA; Salonen JT; Zhelankin AV; Melnichenko AA; Kaikkonen J; Bobryshev YV; Orekhov AN
    Biomed Res Int; 2014; 2014():205697. PubMed ID: 25054132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of low density lipoprotein by desialylation causes lipid accumulation in cultured cells: discovery of desialylated lipoprotein with altered cellular metabolism in the blood of atherosclerotic patients.
    Orekhov AN; Tertov VV; Mukhin DN; Mikhailenko IA
    Biochem Biophys Res Commun; 1989 Jul; 162(1):206-11. PubMed ID: 2751649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desialylated low density lipoprotein--naturally occurring modified lipoprotein with atherogenic potency.
    Orekhov AN; Tertov VV; Mukhin DN
    Atherosclerosis; 1991 Feb; 86(2-3):153-61. PubMed ID: 1872910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similarity between naturally occurring modified desialylated, electronegative and aortic low density lipoprotein.
    Tertov VV; Sobenin IA; Orekhov AN
    Free Radic Res; 1996 Oct; 25(4):313-9. PubMed ID: 8889495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-density lipoprotein modification occurring in human plasma possible mechanism of in vivo lipoprotein desialylation as a primary step of atherogenic modification.
    Tertov VV; Kaplun VV; Sobenin IA; Orekhov AN
    Atherosclerosis; 1998 May; 138(1):183-95. PubMed ID: 9678784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of chemical composition of native and modified low density lipoprotein occurring in the blood of diabetic patients.
    Sobenin IA; Tertov VV; Orekhov AN
    Int Angiol; 1994 Mar; 13(1):78-83. PubMed ID: 8077803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The atherogenic effect of lupus sera: systemic lupus erythematosus-derived immune complexes stimulate the accumulation of cholesterol in cultured smooth muscle cells from human aorta.
    Kabakov AE; Tertov VV; Saenko VA; Poverenny AM; Orekhov AN
    Clin Immunol Immunopathol; 1992 Jun; 63(3):214-20. PubMed ID: 1623641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified (desialylated) low-density lipoprotein measured in serum by lectin-sorbent assay.
    Tertov VV; Sobenin IA; Orekhov AN
    Clin Chem; 1995 Jul; 41(7):1018-21. PubMed ID: 7600681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antioxidant content in low density lipoprotein and lipoprotein oxidation in vivo and in vitro.
    Tertov VV; Sobenin IA; Kaplun VV; Orekhov AN
    Free Radic Res; 1998 Aug; 29(2):165-73. PubMed ID: 9790519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified low density lipoprotein from diabetic patients causes cholesterol accumulation in human intimal aortic cells.
    Sobenin IA; Tertov VV; Koschinsky T; Bünting CE; Slavina ES; Dedov II; Orekhov AN
    Atherosclerosis; 1993 Apr; 100(1):41-54. PubMed ID: 8318062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of atherogenic modified (desialylated) low density lipoprotein from blood of atherosclerotic patients: separation from native lipoprotein by affinity chromatography.
    Tertov VV; Sobenin IA; Tonevitsky AG; Orekhov AN; Smirnov VN
    Biochem Biophys Res Commun; 1990 Mar; 167(3):1122-7. PubMed ID: 2322261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.